UBE2L3 and posterior cortical atrophy: In fact, only the DU145 cell line, among the chosen PCa cell lines, carries a mutation in the oncogenic KRAS gene, resulting in a gene fusion with the ubiquitin-conjugating enzyme UBE2L3 (54).